All In Biotech

Drug Trial Radar · NCT03608033

Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy (ARTEMIS - IGAN)

Last checked: Nov 20, 2026Latest source record: Dec 9, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingPhase 3. Randomized with 360 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

360

Actual

Start

Apr 5, 2018

Primary completion

Jan 12, 2024

Study completion Jan 12, 2024

Sponsor

Lead sponsor
Omeros CorporationIndustry
Sponsor type
Industry
First posted
Jul 31, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to evaluate the effect of OMS721 on 24-hour urine protein excretion (UPE) in IgA nephropathy (IgAN) patients with high baseline proteinuria (high-risk proteinuria group; 24-hour UPE ≥ 2 g/day) assessed at 36 weeks from baseline.

Conditions

  • IgA Nephropathy

Interventions

  • OMS721Biological

    Biological: OMS721

  • Vehicle (D5W or saline)Other

    5% Dextrose in water or normal saline solution

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change in 24-hour UPE in g/Day Compared to BaselineTime frame: 36 Weeks

Locations

139 sites in 23 countries. Site status is shown where the registry gives one.

  • Omeros Investigational Site

    Florence, Alabama

  • Omeros Investigational Site

    Mesa, Arizona

  • Omeros Investigation Sites

    Phoenix, Arizona

  • Omeros Investigational Site

    Scottsdale, Arizona

  • Omeros Investigational Site

    Scottsdale, Arizona

  • Omeros Investigational Site

    Los Angeles, California

  • Omeros Investigational Site

    Los Angeles, California

  • Omeros Investigational Site

    Northridge, California

  • Omeros Investigational Site

    San Dimas, California

  • Omeros Investigational Site

    San Francisco, California

  • Omeros Investigational Site

    Stanford, California

  • Omeros Investigational Site

    Torrance, California

  • Omeros Investigational Site

    Denver, Colorado

  • Omeros Investigational Site

    Miami, Florida

  • Omeros Investigational Site

    Miami Lakes, Florida

  • Omeros Investigational Site

    Lawrenceville, Georgia

  • Omeros Investigational Site

    Chicago, Illinois

  • Omeros Investigational Site

    Iowa City, Iowa

  • Omeros Investigational Site

    Boston, Massachusetts

  • Omeros Investigational Site

    Springfield, Massachusetts

  • Omeros Investigational Site

    Minneapolis, Minnesota

  • Omeros Investigational Site

    Rochester, Minnesota

  • Omeros Investigational Site

    St Louis, Missouri

  • Omeros Investigational Site

    Fresh Meadows, New York

  • Omeros Investigational Site

    New York, New York

  • Omeros Investigational Site

    Cincinnati, Ohio

  • Omeros Investigational Site

    Columbus, Ohio

  • Omeros Investigational Site

    Philadelphia, Pennsylvania

  • Omeros Investigational Site

    Charleston, South Carolina

  • Omeros Investigational Site

    Chattanooga, Tennessee

  • Omeros Investigational Site

    Amarillo, Texas

  • Omeros Investigational Site

    Dallas, Texas

  • Omeros Investigational Site

    Houston, Texas

  • Omeros Investigational Site

    Milwaukee, Wisconsin

  • Omeros Investigational Site

    Buenos Aires, Argentina

  • Omeros Investigational Site

    Córdoba, Argentina

  • Omeros Investigational Site

    Salta, Argentina

  • Omeros Investigational Site

    Posadas, Misiones Province, Argentina

  • Omeros Investigational Site

    Garran, Australian Capital Territory, Woden, Australia

  • Omeros Investigational Site

    Footscray, Saint Albans, Australia

Showing 40 of 139 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.